Skip to content

Comparative roentgen stereophotogrammetry analysis of the Global Tissue Sparing (GTS) stem ® compared with uncemented HA coated Taperloc stem.

Comparative roentgen stereophotogrammetry analysis of the Global Tissue Sparing (GTS) stem ® compared with uncemented HA coated Taperloc stem. - RSA analysis of GTS vs Taperloc stem

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON55416
Enrollment
50
Registered
2012-11-26
Start date
2013-01-21
Completion date
Unknown
Last updated
2024-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

joint wear osteoarthrosis

Interventions

None listed

Sponsors

Haaglanden Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Male and non-pregnant females :

Exclusion criteria

Exclusion criteria: - Patients who had a THA on contralateral side more than 6 months ago and the rehabilitation period outcome is considered unsatisfactory or not good. (Patients with contra-lateral THA >6 months ago with good outcome (Harris Hip Score >85) can be included in the study). - Patients who had a THA on contralateral side less than 6 months ago. - Patients with a major surgical procedure during the 12 weeks before the study-related operation. - Dutch language not mastered - The patient is unwilling to cooperate with the study

Design outcomes

Primary

MeasureTime frame
The primary outcome is stem migration at 2 years postoperatively measured with RSA analysis.

Secondary

MeasureTime frame
Outcome will be clinically measured using the Harris Hip Score (HHS), HOOS (WOMAC) questionnaire, EQ5-D, whilst radiographic outcomes will be evaluated through standard radiographic parameters which include qualitative femoral and acetabular findings as well as position of the stem and cup. RSA will be used to measure stem migration.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)